NovaBay Pharmaceuticals, Inc.
NBY
$0.60
$0.0122.04%
AMEX
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -4.62% | 1.55% | |||
| Total Other Revenue | -117.65% | 30.77% | |||
| Total Revenue | -5.41% | 1.71% | |||
| Cost of Revenue | -4.83% | 4.95% | |||
| Gross Profit | -5.71% | 0.06% | |||
| SG&A Expenses | 4.94% | 0.53% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.74% | 1.42% | |||
| Operating Income | -21.49% | -0.76% | |||
| Income Before Tax | -9.16% | 23.53% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -9.16% | 23.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.00% | 23.53% | |||
| EBIT | -21.49% | -0.76% | |||
| EBITDA | -21.77% | -0.96% | |||
| EPS Basic | 74.63% | 56.45% | |||
| Normalized Basic EPS | 48.81% | 75.15% | |||
| EPS Diluted | 74.63% | 56.45% | |||
| Normalized Diluted EPS | 48.81% | 75.15% | |||
| Average Basic Shares Outstanding | 115.50% | 221.21% | |||
| Average Diluted Shares Outstanding | 115.50% | 221.21% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||